Wubshet is a pharmacist with a credential in medication review and a licensed Mental Health First Aid Instructor at the University of Queensland’s Faculty of Health, Medicine and Behavioural Sciences. He also holds an Affiliate Research Fellow position at the University of Sydney School of Pharmacy. Currently, he is the fourth-year course coordinator for Pharmacy Practice and Medicines Management in the BPharm (Hons) program. He completed his PhD at the University of Tasmania in 2019. Following that, he held postdoctoral researcher roles at the University of Canberra and University of Sydney, where he coordinated multiple government- and industry-funded clinical trials. Wubshet's research primarily centres around understanding medication and patient outcomes in individuals with chronic diseases, with a special emphasis on kidney diseases. In collaboration with several researchers and stakeholders in Australia, Wubshet has attracted ~$2.1 million in grant funding. Currently, he is actively involved as an investigator in a large-scale cluster randomised trial (ACTRN12622000329763) funded by the Medical Research Future Fund and led by the University of Sydney. This trial is investigating the effectiveness of a community pharmacy-led point-of-care screening in improving the detection of chronic kidney disease and quality use of medicines.

Dr Aili Langford is a pharmacist, Lecturer and National Health and Medical Research Council (NHRMRC) Emerging Leader Research Fellow at the Sydney Pharmacy School. Dr Langford’s research focuses on reducing medication-related harm through deprescribing.

Brendan recently completed his PhD in the laboratory of Nicola Smith at UNSW Sydney. He is now a Lecturer in the Department of Pharmacology in the School of Biomedical Sciences at UNSW Sydney. Brendan has a special interest in G protein-coupled receptors, particularly those that do not yet have an identified endogenous ligand which are termed “orphans”. Brendan is the chair-elect of the ASCEPT Equity, Diversity, and Inclusion Committee and is committed to improving the visibility of the ASCEPT LGBTQIA+ community.

George is a Research Fellow in Pharmacoepidemiology and Real-world Evidence at the Centre for Medicine Use and Safety, Monash University. His research focuses on generating real-world evidence on medication use patterns and outcomes. George has a specific interest in generating and validating drug repurposing hypotheses using real-world data. George currently serves as the Deputy Chair of the ASCEPT Pharmacoepidemiology SIG. George also teaches undergraduate and postgraduate topics such as Medication Safety, Evidence-based Practice, as well as coordinating the Objective Structured Clinical Examinations (OSCEs). He is also a practising pharmacist, with experience in both community and hospital pharmacy.